TLR2 and breast carcinoma: In breast cancer, the extracellular HSP90 co-chaperone Morgana acts as another significant activator of TLR2 [35], whereas versican has been identified as the DAMP involved in TLR2-mediated tumor promotion in glioma and lung cancer [36].